Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sleep Quality Among Students in Sohag University.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04716283
Recruitment Status : Recruiting
First Posted : January 20, 2021
Last Update Posted : October 28, 2021
Sponsor:
Information provided by (Responsible Party):
Dalia Saad Louis, Sohag University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The study will be done among undergraduate students in Sohag University for assessment of quality of sleep and its determinants .It will be done in practical faculties and theoretical faculties .

Condition or disease Intervention/treatment
Sleep Other: Validated questionnaire : The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS)

Detailed Description:

Sleep is very necessary to our physical and mental health. Sleep is classified into satisfactory and unsatisfactory sleep. Good sleep is sleep which is sufficient in duration and has a good quality while bad sleep is the sleep which makes individual feels unsatisfactory .

University students are exposed to poor sleep, due to high work and study loads. Poor quality sleep has negative consequences on the daily life activities , associated with memory reduction , reduced learning abilities which ultimately can lead to reduce their academic achievements, and can also trigger negative health outcomes, such as mood disturbance, fatigue, impaired concentration .

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 400 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Sleep Quality and Its Determinants Among Students in Sohag University.
Actual Study Start Date : March 15, 2021
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : October 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: College Health

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Other: Validated questionnaire : The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS)

    The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score.

    The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness .The ESS is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3), their usual chances of dozing off or falling asleep while engaged in eight different activities.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Pittsburgh Sleep Quality Index [PSQI] [ Time Frame: It will be measured after completion of the study ,approximately in october 2022. ]
    A questionnaire will be used to measure sleep quality over the last 1 month .The self-related questions include the assessment of seven different sleep domains : sleep quality, sleep latency , sleep duration , habitual sleep efficiency, sleep disturbances , use of sleeping medications , and daytime dysfunction .The seven components scores are then added to yield a global PSQI score in the range of zero to 21. The higher the score, the worse the sleep quality. A global score greater than five is diagnostic of poor sleep quality.

  2. Epworth Sleepiness Scale [ESS] [ Time Frame: It will be measured after completion of the study ,approximately in octuber 2022. ]
    A questionnaire will be used to measure daytime sleepiness .It can determine the chance of falling asleep in 8 different circumstances. ESS score can range from 0 to 24. A global score greater than ten is diagnostic of excessive daytime sleepiness .


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 24 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

The study will be conducted in Sohag University where there are ten practical faculties and six theoretical faculties .

Two practical faculties [ faculty of medicine and faculty of nursing ] and two theoretical faculties [faculty of Education and faculty

of commerce] were chosen randomly to be the setting of the study.

Criteria

Inclusion Criteria:

  • students who are in the first four years in the selected faculties .

Exclusion Criteria:

  • students who will refuse to participate in this study.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04716283


Contacts
Layout table for location contacts
Contact: Dalia S Louis, Demonstrator +20 01229722449 daliasaad.2@med.sohag.edu.eg
Contact: Nesreen A Mohammed, Lecturer +20 1017617763 nesreen2025@yahoo.com

Locations
Layout table for location information
Egypt
Sohag University Recruiting
Sohag, Egypt, 82524
Contact: Dalia S Louis, Demonstrator    +201229722449    daliasaad.2@med.sohag.edu   
Contact: Nesreen A Mohammed, Lecturer    +21017617763    nesreen2025@yahoo.com   
Sohag University Recruiting
Sohag, Egypt, Sohag University82524
Contact: Dalia S Louis, Demonstrator    +201229722449    daliasaad.2@med.sohag.edu   
Contact: Nesreen A Mohammed, Lecturer    +21017617763    nesreen2025@yahoo.com   
Sponsors and Collaborators
Sohag University
Investigators
Layout table for investigator information
Principal Investigator: Dalia S Louis, Demonstrator Faculty of Medicine -Sohag University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Dalia Saad Louis, Demonstrator in Public Health and Community Medicine, Sohag University
ClinicalTrials.gov Identifier: NCT04716283    
Other Study ID Numbers: soh-Med-21-01-01
First Posted: January 20, 2021    Key Record Dates
Last Update Posted: October 28, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No